CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- Open-market buys, last 90 days
- $356,328
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$356,328. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-03-29 | ROBERTSON SANFORD Director | Option exercise | +32,811 | $6.76 | $222K | 276,830 |
| 2011-03-29 | ROBERTSON SANFORD Director | Option exercise · Common Stock | −32,811 | $6.76 | $222K | 337,189 |
| 2011-03-14 | BARBIER REMI CEO & Chairman of the Board | Option exercise | +1,968 | $6.10 | $12K | 5,944,441 |
| 2011-03-14 | BARBIER REMI CEO & Chairman of the Board | Shares withheld for taxes | −1,388 | $6.10 | $8K | 5,943,053 |
| 2011-03-14 | BARBIER REMI CEO & Chairman of the Board | Option exercise · Common Stock | −1,968 | $6.10 | $12K | 3,937,492 |
| 2011-03-04 | BARBIER REMI CEO & Chairman of the Board | Gift | −20,900 | 5,942,473 | ||
| 2011-03-04 | BARBIER REMI CEO & Chairman of the Board | Gift | +7,600 | 55,975 | ||
| 2011-02-28 | SCHOENHARD GRANT Director | Option exercise | +67,592 | $6.10 | $412K | 115,779 |
| 2011-02-28 | SCHOENHARD GRANT Director | Shares withheld for taxes | −60,280 | $6.84 | $412K | 55,499 |
| 2011-02-28 | SCHOENHARD GRANT Director | Option exercise · Common Stock | −67,592 | $6.10 | $412K | 817,024 |
| 2010-12-23 | RODDY PETER S Chief Financial Officer | Grant or award | +12,465 | 56,522 | ||
| 2010-12-23 | FRIEDMANN NADAV Chief Operating Officer | Grant or award | +4,826 | 282,665 | ||
| 2010-12-23 | BARBIER REMI CEO, Chairman of the Board | Grant or award | +33,786 | 5,963,373 | ||
| 2010-11-01 | RODDY PETER S Chief Financial Officer | Other acquisition | +1,661 | $3.77 | $6K | 44,057 |
| 2010-11-01 | FRIEDMANN NADAV Chief Operating Officer | Other acquisition | +1,888 | $3.77 | $7K | 277,839 |
| 2010-10-04 | BARBIER REMI CEO & Chairman of the Board | Sale | −15,000 | $6.13 | $92K | 5,929,587 |
| 2010-10-01 | BARBIER REMI CEO & Chairman of the Board | Sale | −35,000 | $6.23 | $218K | 5,944,587 |
| 2010-09-17 | SCANNON PATRICK J MD PHD Director | Grant or award · Non-Qualified Stock Options | +15,000 | $6.12 | $92K | 160,000 |
| 2010-09-17 | ROBERTSON SANFORD Director | Grant or award · Non-Qualified Stock Options | +15,000 | $6.12 | $92K | 370,000 |
| 2010-09-17 | GUSSIN ROBERT Z Director | Grant or award · Non-Qualified Stock Options | +15,000 | $6.12 | $92K | 345,000 |
Page 21 of 25 · 498 trades